
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
PRNewsWire
公開日時: Sep 24, 2026, 07:28 AM GMT+9
Sentiment Analysis
Aurora has filed an application with the Alberta Securities Commission for an order requiring Curaleaf to comply with securities laws. Aurora intends to demonstrate that Curaleaf's Circular has not satisfied several regulatory requirements, impacting Aurora Shareholders, including providing pro-forma financials and keeping the hostile bid open for the minimum period. Curaleaf has refused to address deficiencies identified by Aurora in its hostile bid Circular that are believed to limit Aurora shareholders' access to disclosures required by securities laws before responding to its hostile bid. Aurora is committed to protecting shareholders' ability to make a fully informed decision regarding Curaleaf's hostile bid. Aurora's Special Committee and Board have unanimously recommended that shareholders REJECT Curaleaf's hostile bid by TAKING NO ACTION and NOT TENDERING their shares. EDMONTON, AB , Sept. 23, 2026 /PRNewswire/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB ) (TSX: ACB), the Canadian-based leading global medical cannabis company, today filed an application with the Alberta Securities Commission ("ASC') for an order requiring Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF ) to address several deficiencies Aurora has identified in its hostile bid Circular and to require Curaleaf to comply with securities law requirements. "We believe Curaleaf has failed to comply with applicable securities law requirements in connection with its hostile bid, and Aurora intends to vigorously defend its interests and those of its shareholders. Aurora is taking the necessary steps to protect its shareholders' rights, which this hostile bid is clearly ignoring," said Miguel Martin, Executive Chairman and Chief Executive Officer of Aurora. "Aurora's review of Curaleaf's hostile bid circular uncovered several significant deficiencies, which were highlighted in the Directors' Circular issued on September 2. Aurora also wrote directly to Curaleaf to ask that it remedy these failings. Curaleaf has refused to do so. As a result, Aurora has applied to the Alberta Securities Commission for an order requiring compliance with applicable securities laws. These are not technicalities. They are shareholder protection requirements, and they matter," concluded Mr. Martin. The deficiencies Aurora has identified in Curaleaf's Circular are concerning as they may deprive shareholders of information and time needed to fully evaluate Curaleaf's hostile bid. Aurora's application seeks to have the Alberta Securities Commission review and address the following: Failure to provide pro forma financial statements that would allow Aurora shareholders to understand the financial condition of the combined company if the hostile bid were successful; Failure to hold the hostile bid open for the minimum deposit period required by securities laws, which allows Aurora shareholders the full amount of time required by law to consider the hostile bid; and Failure to publish notice of its hostile bid in a French language publication, denying French-speaking Aurora shareholders from obtaining important information about the commencement of the hostile bid. These requirements are designed to ensure that Aurora shareholders have the time and information they need to make a fair, informed decision about this hostile bid. Aurora intends to demonstrate that these deficiencies deny Aurora shareholders from fundamental protections afforded under securities law. In addition, Curaleaf's failure to comply with the required 105-day deposit period means that the hostile bid does not qualify as a "permitted bid" under Aurora's Shareholder Rights Plan, contrary to Curaleaf's disclosure in its hostile bid Circular. The Rights Plan will be triggered if Curaleaf proceeds to acquire more than 20% of Aurora's shares. Aurora will ask the ASC to order Curaleaf to correct what is has identified as material deficiencies in i...
Source: PRNewsWire
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。